Patents
Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
10/2007
10/11/2007US20070238751 Muscarinic Acetylcholine Receptor Antagonists
10/10/2007CN101052623A Phenanthridine carbonyl phenols as cytokine modulators
10/10/2007CN101052622A Opiate intermediates and methods of synthesis
10/10/2007CN100341947C Method for the production of perylen-3,4:9,10-tetracarboxylic acid diimides and perylen-3,4:9,10-tetracarboxylic acid dianhydride and naphtalene-1,8-dicarboxylimides
10/10/2007CN100341873C Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
10/10/2007CN100341856C Gabapentin hydrochloride preparing process
10/09/2007US7279486 Therapy and prophylaxis of pain, central nervous system diseases; 2-Benzyl-3-(2,3-dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)propanoic acid trifluoroacetate
10/09/2007US7279471 Butane-1,4-diones 1-substituted by a phenyltriazonylpiperidinyl- or benzo-1,3-diazepinonylpiperidinyl- group, e.g., (1) 1-(1,4'-bipiperidinyl-1'-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5,-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butane-1,4-dione; treating headaches, diabetes
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/04/2007US20070232637 Combinations Comprising Antimuscarinic Agents and Pde4 Inhibitors
10/03/2007EP1838676A1 Nepetalactams and n-substituted derivatives thereof
10/03/2007EP1272471B1 Non-steroidal, tetracyclic compounds for estrogen-related treatments
10/03/2007CN101048403A Heterocyclic antiviral compounds
10/03/2007CN101045708A Helicid hydrastine acetali mine its preparation method and its application
10/03/2007CN100340562C Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/03/2007CN100340558C N,N-dipyridyl 3,4,9,10-tetraformyl diimine derirative and its synthesis method
10/03/2007CN100340549C Method for separating and purifying novel alkali B of cohosh root
10/02/2007US7276607 5-HT7 receptor antagonists
10/02/2007US7276606 Phenantridine analogues and uses thereof
10/02/2007US7276539 In which the phenyl group is p-substituted with a 2-(p-(methylsulfonyloxy)phenoxy)ethyl group; used for treating type 2 diabetes and dyslipidemia; may be combined with atorvastatin, rosuvastatin, or an IBAT inhibitor.
10/02/2007US7276513 Steroidal compounds for inhibiting steroid sulphatase
10/02/2007CA2401229C Aryl fused azapolycyclic compounds
09/2007
09/27/2007WO2007025009A3 Indenoisoquinolinone analogs and methods of use thereof
09/27/2007US20070225232 Tetrahydro-Imidazo [1,5-A] Pyridyin Derivatives as Aldosterone Synthase Inhibitors
09/27/2007US20070222373 Naphthacene derivative and organic electroluminescent device using the same
09/26/2007EP1836183A2 Spiro derivatives as lipoxygenase inhibitors
09/26/2007EP1836172A1 5-ht7 receptor antagonists
09/26/2007CN100339377C Camptothecine derivative and its preparation
09/25/2007US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
09/20/2007WO2007105823A1 Prophylactic/therapeutic agent for alzheimer's disease
09/20/2007WO2007104214A1 Camptothecin derivatives and their use
09/20/2007WO2006113509A3 Quinobenzoxazine analogs and methods of using thereof
09/20/2007CA2645289A1 Pyridine-containing macroheterocylic compounds as kinase inhibitors
09/19/2007EP1511517B1 Formulation for parenteral administration of sodium channel blockers
09/19/2007CN101039900A 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
09/19/2007CN101037412A Method for extracting chasmanine from aconitum sungpanense hand-mazz
09/19/2007CN100338066C Hexacyclic compounds
09/19/2007CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/18/2007US7271175 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia
09/18/2007US7271174 Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases
09/18/2007US7271173 Mixed kappa/mu opioids and uses thereof
09/13/2007US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders
09/12/2007EP1831175A1 Dihydronepetalactams and n-substituted derivatives thereof
09/12/2007EP1831150A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester
09/12/2007CN101033225A Process of preparing troipisetron
09/11/2007US7268232 Androgen receptor modulators and method of treating disease using the same
09/11/2007US7268143 Isoquinoline derivatives and methods of use thereof
09/07/2007CA2643320A1 Modulators of muscarinic receptors
09/07/2007CA2638734A1 Inhibitors of the unfolded protein response and methods for their use
09/06/2007US20070208175 Condensing cyclohexanone with cyanoacetamide and reacting 2-cyclohexylidene-2-cyanoacetamide formed with malonate to form 3-cyano-5-carboxy-2,4-dioxo-3-azaspiro[5,5]undecane (claimed as an intermediate); hydrolysis, decarboxylation and further hydrolysis to form 3,3-pentamethyleneglutaramic acid
09/05/2007EP1828258A1 N-substituted imides as polymerization initiators
09/05/2007EP1828184A1 [1,2,4]triazolo[4,3-a]pyridine derivatives for the treatment of hyperproliferative diseases
09/05/2007CN101029051A (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor
09/05/2007CN100335483C Double piperazine quaternary ammonium salt compound with analgetic function
09/05/2007CN100335481C Poly-substituted pyridino-[4,3d] pyramine with antibacterial and herbicide activity and its production thereof
09/05/2007CN100335480C New imidazopyrdine derivatives, its preparation method and medicine composition containing same
09/05/2007CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3
09/04/2007US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
09/04/2007US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
09/04/2007US7265150 E.g., [(2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-hydroxymethylpyrrolidine; (2S)-1-(1, 2-dioxo-3,3-dimethylpentyl)-2-pyrrolidinetetrazole; (2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-pyrrolidinecarbonitrile; and 2S)-1-(1,2-dioxo-3,3-dimethylpentyl)-2-aminocarbonyl piperidine
09/04/2007US7265119 For therapy of nicotine dependency
09/04/2007CA2297911C Substituted 6-phenylphenanthridines
08/2007
08/30/2007US20070203180 e.g. 4-[(7-Hydroxy-2-ethyl-3-phenyl-4-quinolinyl)oxyphenyl]-2-propenoic acid; bone diseases, aging, osteoporosis, osteoarthritis, atherosclerosis, menopausal disorders,liver and cardiovascular disorder, breast cancer
08/29/2007EP1824856A1 2,4 (4,6) pyrimidine derivatives
08/29/2007EP1824828A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
08/29/2007EP1824820A2 Substituted tetracyclic tetrahydrofuran,pyrrolidine and tetrahydrothiophene derivatives
08/29/2007EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
08/29/2007CN101027307A Preparation of opiate analgesics by reductive alkylation
08/29/2007CN101027277A Process for the preparation of (2R, 3R)-2-hydroxy-3-amino-3-aryl-propionamide and (2R, 3R)-2-hydroxy-3-amino-3-aryl-propionic acid alkylester
08/29/2007CN100334089C Production method of 9-nitro camptothecin
08/28/2007US7262299 Diels-Alder reaction; using zeolite y in exchanged with copper; separated from mixture for reuse
08/28/2007US7262298 4-hydroxybenzomorphans
08/28/2007CA2230960C Piperazine derivatives and process for the preparation thereof
08/23/2007WO2007008502A3 Inhibitors of checkpoint kinases
08/23/2007US20070197500 3-(2,3-Dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)-N,N-dimethyl-2-(pyridin-2-ylmethyl)propanamide; opioid receptor-like 1 antagonist; reduced inhibitory activity at HERG potassium channel; analgesic; side effect reduction; neurpathic and other pain
08/22/2007EP1819678A1 Rylene tetracarboxylic acid diimides substituted by cyclic amino groups
08/22/2007EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof
08/22/2007EP1567502B1 Substituted dihydrophenanthridinesul fonamides
08/22/2007EP1373214B1 Rylene derivatives and their use as dyes
08/22/2007CN1332962C Method of synthesizing methanesulfonic acid parzhushaxing intermedinte
08/22/2007CN1332950C Improved compounds for generating chemiluminescence with peroxidase
08/22/2007CN101020660A Process of extracting huperzine B from plant medicine material huperzine serrate
08/22/2007CN101020659A 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application
08/22/2007CN101019866A Medicine for treating hepatitis B
08/16/2007US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
08/16/2007US20070191414 Novel isoamido-substituted hydroxy-6-phenylphenanthridines
08/16/2007US20070191413 Novel heterocycle-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
08/16/2007US20070189987 Composition comprising a monomeric compound with an optical effect, process using said composition, monomeric compound, polymer comprising the same and use thereof
08/16/2007DE102006005937A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis
08/16/2007DE102006005936A1 New fredericamycin derivatives are topoisomerase I inhibitors useful to treat tumor, parasite, immunosupression and neurodermititis
08/15/2007EP1817291A1 4-hydroxybenzomorphans
08/15/2007EP1817290A2 Luminescent indicator dye and optical sensor
08/15/2007EP1458724B1 Total synthesis of galanthamine, analogues and derivatives thereof
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists
08/14/2007US7256292 Acridinone based multiple ring fluorescent dyes, linkable forms of fluorescent dyes, energy transfer dyes, reagents labeled with fluorescent dyes
08/14/2007US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/09/2007WO2007089044A1 Process for production of aromatic compound
08/09/2007US20070185159 Novel Nitrogen-Containing Heteroaryl Compounds And Methods of Use Thereof
08/09/2007US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 110